Alzheimer's disease drug development pipeline: 2021-Reference-Cited by-同舟云学术

Alzheimer's disease drug development pipeline: 2021

Published:2021-01 Issue:1 Volume:7 Page:
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:A&D Transl Res & Clin Interv

Author:

Cummings Jeffrey¹,Lee Garam²,Zhong Kate³,Fonseca Jorge⁴,Taghva Kazem⁴

Affiliation:

1. Chambers‐Grundy Center for Transformative Neuroscience Department of Brain Health School of Allied Health Sciences, University of Nevada, Las Vegas (UNLV) Las Vegas Nevada USA

2. Biogen Weston Massachusetts USA

3. Department of Brain Health School of Allied Health Sciences University of Nevada, Las Vegas (UNLV) Las Vegas Nevada USA

4. Howard R. Hughes College of Engineering Department of Computer Science University of Nevada, Las Vegas (UNLV) Las Vegas Nevada USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/trc2.12179

Reference43 articles.

1. 2020 Alzheimer's disease facts and figures

2. Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype

3. Alzheimer's disease

Cited by 322 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline serum glutamate: Implications for diagnosis and prediction in mild cognitive impairment and Alzheimer’s disease of the Alzheimer’s Disease Neuroimaging Initiative;Journal of Clinical Neuroscience;2024-11

2. Cellular senescence: A novel therapeutic target for central nervous system diseases;Biomedicine & Pharmacotherapy;2024-10

3. Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease;Frontiers in Cellular Neuroscience;2024-09-02

4. On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-08-27

5. Recent Molecular Targets and Their Ligands for the Treatment of Alzheimer Disease;Current Topics in Medicinal Chemistry;2024-08-20